Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia

International Journal of Radiation Oncology, Biology, Physics
Christopher J TyrrellKevin Carroll

Abstract

To evaluate the efficacy and tolerability of prophylactic breast irradiation in reducing the incidence and severity of bicalutamide-induced gynecomastia and breast pain. In all, 106 men with prostate cancer (T1b-T4/Nx/M0) and no current gynecomastia/breast pain were enrolled in this randomized, sham-controlled, double-blind, parallel-group multicenter trial. Patients received either a single dose of electron beam radiotherapy (10 Gy) or sham radiotherapy. Bicalutamide (Casodex) 150 mg/day was administered for 12 months from the day of radiotherapy. Every 3 months, patients underwent physical examination and questioning about gynecomastia and breast pain. The incidence of investigator-assessed gynecomastia was significantly lower with radiotherapy vs. sham radiotherapy (52% vs. 85%; odds ratio [OR], 0.13; 95% confidence interval [CI], 0.04, 0.38; p < 0.001); direct questioning showed similar results. Fewer radiotherapy patients had >/=5 cm gynecomastia (measured by calipers; 11.5% vs. 50.0% for sham radiotherapy), and fewer cases were moderate-to-severe in intensity (21% vs. 48%). Similar proportions of radiotherapy and sham radiotherapy patients experienced breast pain (83% vs. 91%; OR, 0.25; 95% CI, 0.05, 1.27; p = 0.221); pat...Continue Reading

References

Nov 1, 1989·International Journal of Radiation Biology·H D ThamesW van den Bogaert
Jan 1, 1969·Scandinavian Journal of Urology and Nephrology·O Alfthan, L R Holsti
Aug 1, 1969·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·J G CorvalanA Rodriguez-Antunez
Jul 8, 2000·The British Journal of Radiology·C Abson

❮ Previous
Next ❯

Citations

Aug 10, 2006·Journal of Cancer Research and Clinical Oncology·Heather Payne
Aug 10, 2006·Journal of Cancer Research and Clinical Oncology·William A SeeUNKNOWN CASODEX Early Prostate Cancer Trialists' Group
Jul 18, 2006·Journal of Cancer Research and Clinical Oncology·David Gillatt
Jun 19, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Montero LuisA Ramos Aguerri
Feb 14, 2006·Nature Clinical Practice. Urology·Roger Kirby
Nov 1, 2007·Journal of the National Cancer Institute·Carsten NiederMichael Molls
Mar 8, 2006·Anti-cancer Drugs·Roger Kirby, Nigel Offen
May 15, 2008·Journal of Medical Imaging and Radiation Oncology·F Schwarz, D Christie
Mar 17, 2007·International Journal of Clinical Practice·P Gikas, K Mokbel
Apr 12, 2011·Therapeutics and Clinical Risk Management·Ruth E JohnsonM Hassan Murad
Dec 1, 2011·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Burkhard NeuMarie-Luise Sautter-Bihl
Feb 15, 2013·The Journal of Sexual Medicine·Landon W TrostWayne J G Hellstrom
Jan 30, 2009·The Journal of Sexual Medicine·Richard J Wassersug, John L Oliffe
May 30, 2006·Hematology/oncology Clinics of North America·Tony Y EngC R Thomas
Jul 25, 2006·Hematology/oncology Clinics of North America·Celestia Higano
Jan 25, 2006·BJU International·David G McLeodUNKNOWN Casodex Early Prostate Cancer Trialists' Group
Dec 3, 2005·The Lancet Oncology·Giuseppe Di LorenzoSabino De Placido
Jun 19, 2012·International Journal of Radiation Oncology, Biology, Physics·Gustavo Arruda VianiEduardo Jose Stefano
Feb 25, 2015·Nature Reviews. Urology·Jahan J MohiuddinRonald C Chen
Aug 27, 2015·PloS One·Anders FagerlundGennaro Selvaggi
Mar 17, 2007·Annales D'urologie·E Haddad
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel Thönnessen, Frederik Wenz
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Celestia S Higano
Jan 30, 2007·European Urology·Giuseppe Di Lorenzo, Riccardo Autorino
Jan 25, 2006·Prostate Cancer and Prostatic Diseases·R AutorinoG Di Lorenzo
Dec 8, 2007·Expert Review of Anticancer Therapy·Paul R Sieber
Jan 19, 2008·Expert Opinion on Pharmacotherapy·Eric A SingerEdward M Messing
Mar 28, 2008·Expert Review of Anticancer Therapy·Peter Iversen, Martin Andreas Roder
Mar 14, 2020·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Pirus GhadjarUNKNOWN Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and The Working Party Radiation Oncology of
Jun 17, 2020·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Marigdalia K Ramirez-FortMigdalia Fort
May 26, 2021·Andrology·Evangelia BillaDimitrios G Goulis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.